Diverse Clinical Presentations of C3 Dominant Glomerulonephritis
C3 dominant immunofluorescence staining is present in a subset of patients with idiopathic immune complex membranoproliferative glomerulonephritis (iMPGN). It is increasingly recognized that iMPGN may be complement driven, as are cases of “typical” C3 glomerulopathy (C3G). In both iMPGN and C3G, a f...
Main Authors: | Ramy M. Hanna, Jean Hou, Huma Hasnain, Farid Arman, Umut Selamet, James Wilson, Samuel Olanrewaju, Jonathan E. Zuckerman, Marina Barsoum, Julie M. Yabu, Ira Kurtz |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-06-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fmed.2020.00293/full |
Similar Items
-
Assessment of Treatment Response of Iraqi Patients with Membranoproliferative Glomerulonephritis with Emphasis on Renal Function and Proteinuria Regression
by: Faiz Rashid Abayechi
Published: (2019-07-01) -
Assessment of Treatment Response of Iraqi Patients with Membranoproliferative Glomerulonephritis with Emphasis on Renal Function and Proteinuria Regression
by: Faiz Rashid Abayechi
Published: (2019-07-01) -
Comprehensive review of membranoproliferative glomerulonephritis: spotlighting the latest advances in revised classification and treatment
by: Jeong Yeon Kim
Published: (2023-12-01) -
The impact of reclassification of C3 predominant glomerulopathies on diagnostic accuracy, outcome and prognosis in patients with C3 glomerulonephritis
by: P. Puri, et al.
Published: (2020-07-01) -
Clinico-Pathogenic Similarities and Differences between Infection-Related Glomerulonephritis and C3 Glomerulopathy
by: Yukihiro Wada, et al.
Published: (2023-05-01)